Table 4 |
||||
|
Results of probit model analysis to predict in-hospital mortality |
||||
|
Single probit model |
Bivariate probit model |
|||
|
|
|
|||
|
Marginal effect (95% C.I.) |
Marginal effect (95% C.I.) |
|||
|
|
||||
|
Age (by 10 years) |
0.002* |
( 0.000, 0.004) |
0.002 |
(-0.000, 0.003) |
|
Gender (Female) |
-0.000 |
(-0.004, 0.003) |
-0.000 |
(-0.003, 0.002) |
|
mRS pre-admission |
||||
|
mRS = 0 |
- |
|||
|
mRS = 1 |
-0.001 |
(-0.006, 0.003) |
-0.001 |
(-0.005, 0.002) |
|
mRS = 2 |
0.003 |
(-0.004, 0.010) |
0.002 |
(-0.004, 0.008) |
|
mRS = 3 |
0.003 |
(-0.004, 0.010) |
0.002 |
(-0.003, 0.007) |
|
Functional severity score¶ |
0.004** |
(0.003, 0.006) |
0.003* |
(0.001, 0.006) |
|
Functional capability score¶ |
0.002* |
(0.000, 0.003) |
0.001 |
(-0.000, 0.002) |
|
Co-morbidity index (CI > 2) |
0.003 |
(-0.001, 0.006) |
0.002 |
(-0.001, 0.005) |
|
Use of edaravone |
0.002 |
(-0.002, 0.005) |
0.001 |
(-0.002, 0.005) |
|
VEI |
0.003 |
(-0.000, 0.006) |
0.001 |
(-0.013, 0.016) |
|
Training intensity |
-0.005** |
(-0.007, -0.003) |
-0.004* |
(-0.007, 0.000) |
|
First stage regression |
||||
|
Friday admission |
-0.001 |
(-0.002, 0.000) |
||
|
|
||||
|
N = 5,482 In the bivariate probit model: ρ = 0.04 [-0.59, 0.64], p = 0.91 CI: Charlson's index; mRS: modified Rankin scale; VEI: very early intervention ¶: Functional severity score indicates the principal component of patient severity. Larger values indicate more severe patient conditions. Functional capability score is the principal component of patient functional capability. Larger values indicate better function. |
||||
|
Matsui et al. BMC Health Services Research 2010 10:213 doi:10.1186/1472-6963-10-213 |
||||